Helicobacter Pylori Diagnostics Market

1
Helicobacter Pylori Diagnostics Market 

• Helicobacter Pylori Diagnostics Market to Reach
  926.8 Million, Globally, by 2032 at 5.3 CAGR
  Allied Market Research

2
Prime Determinants of Growth

• The global Helicobacter pylori diagnostics market
  is experiencing growth due to several factors,
  including the rise in prevalence of infectious
  diseases, an increase in demand for non-invasive
  diagnostic procedures, and the development of new
  and improved testing methods. However, the lack
  of awareness and shortage of skilled
  professionals restrict market growth. Moreover,
  the rise in demand for point-of-care H. pylori
  testing presents new opportunities in the coming
  years.

3
(No Transcript)
4
Leading Market Players

• Thermo Fisher Scientific Inc.
• Meridian Bioscience, Inc.
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Cardinal Health Inc.
• Avanos Medical, Inc.
• Gulf Coast Scientific
• Quidel Corporation
• Biohit Oyj

5
In March 2020, Meridian Bioscience, Inc.
announced that it received FDA-clearance for
Meridians new Curian and Curian HpSA assay.  In
August 2021, the latest innovation in the unique
Biohit GastroPanel product family, GastroPanel
quick test, received the CE marked approval. In
January 2023, Meridian Bioscience, Inc. and SD
Biosensor, Inc. and SJL Partners LLC announced
that they have completed the transaction to
acquire Meridian.
Recent Developments 
6
Contact

• David Correa
• 5933 NE Win Sivers Drive205, Portland,
  OR 97220United StatesToll Free
  1-800-792-5285 UK 44-845-528-1300Hong Kong
  852-301-84916India (Pune) 91-20-66346060Fax
  1-855-550-5975
• help_at_alliedmarketresearch.com
• Web https//www.alliedmarketresearch.com  Follo
  w Us on LinkedIn Twitter